NATCO Pharma

BSE : 524816 | NSE : NATCOPHARM

Industry : Pharmaceuticals | ISIN : INE987B01026 | FreeFloat : 45.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)1,498.69
Net Worth (NW)3,784.70
Intrinsic Worth (IW)5,283.39
Market Cap (MC)9,204.45
Economic Value Added-44.58
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)28.37%
IC Gross Margin (EBITDA/IC)47.87%
IC Net Margin (NPT/IC)29.82%
Knowledge Turnover (Sales/IC)1.30
Market to Intrinsic Value (MC/IW)1.74

As OfIntrinsic ValueMarket Price
31 Mar 2020Rs. 290.19Rs. 505.55
7 Aug 2020 - Rs. 781.75
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 760.79BuyHold
KB > 50% : No50 DMA : Rs. 669.22
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-17
C
445.30
448.70
140.10
125.10
121.20
93.70
97.40
Sep-17
C
426.70
432.20
127.40
111.40
107.20
84.40
84.10
Dec-17
C
562.20
573.60
297.90
280.70
276.40
217.40
216.70
Mar-18
C
767.80
787.90
403.40
385.40
382.40
299.70
291.80
Jun-18
C
538.60
574.50
253.50
235.10
232.30
181.10
182.40
Sep-18
C
543.50
583.50
260.50
240.30
235.30
181.60
181.10
Dec-18
C
556.70
580.00
231.70
211.00
204.70
159.30
154.30
Mar-19
C
455.70
486.70
179.30
157.60
152.40
120.40
117.00
Jun-19
C
492.30
513.30
212.30
190.30
183.80
142.80
144.50
Sep-19
C
485.70
518.90
167.50
145.60
139.40
117.70
118.60
Dec-19
C
482.20
513.00
159.50
134.10
128.80
104.40
105.00
Mar-20
C
454.80
477.20
150.70
120.20
116.70
93.20
75.50
* C - Consolidated, S - Standalone